Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TARLATAMAB: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

34.0%
Female
66.0%
Male

Age Information

The average age of patients reporting adverse events with TARLATAMAB is 62.7 years.

Geographic Distribution

The majority of adverse event reports for TARLATAMAB originate from US.

Report Summary & Outcomes

145
Total Reports
145
As Primary/Secondary Suspect
49
Deaths Reported
52
Hospitalizations
6
Life-Threatening

Reporting Timeline

First adverse event report: 20230420. Most recent report: 20250715. View full timeline →

More About TARLATAMAB

TARLATAMAB Full Profile Reports by Year Drug Interactions